Research on the preferences of patients with AD, caregivers, and health care providers may be influenced by pharmaceutical company sponsorship.

Routine SLNB may be used to predict tumor invasion levels and SLN metastasis in patients with EMPD who do not have enlarged lymph nodes.

Here are five signs of heart disease that may show up on your skin: The NHS said that the “net” this condition causes shows ...

Cambridge Investment Research Advisors Inc. boosted its holdings in Journey Medical Corporation (NASDAQ:DERM – Free Report) ...